Clinical trial
Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's…
NCT00359944 · Sumitomo Pharma America, Inc., Industry · Completed
Key facts
| NCT number | NCT00359944 |
|---|---|
| Title | Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease |
| Official title | A Phase II, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Assessing the Efficacy and Safety of AC-3933 Tablets Twice Daily in Adults With Mild to Moderate Alzheimer's Disease |
| Lead sponsor | Sumitomo Pharma America, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug, Other |
| Interventions | AC-3933, Sugar Pill |
| Enrollment | 171 |
| Start date | Feb 1, 2006 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Aug 3, 2006 |
| Last update posted | Jul 2, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: